OTCMKTS:SIGY Sigyn Therapeutics Q3 Earnings Results & Report $0.03 -0.01 (-16.67%) As of 03:59 PM Eastern Sigyn Therapeutics reported Q3 earnings on December 2, 2025. The company reported EPS of $0.49. Research:ProfileEarnings History Earnings Announcement Details QuarterQ3Report DateDecember 2, 2025TimeBefore Market Opens Sigyn Therapeutics EPS ResultsActual EPS$0.49Consensus EPS N/ABeat/MissN/AOne Year Ago EPS$0.24Sigyn Therapeutics Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AUpcoming EarningsSigyn Therapeutics' next earnings date is estimated for Wednesday, November 18, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Sigyn Therapeutics Q3 Earnings FAQ Did Sigyn Therapeutics beat earnings estimates for Q3? Sigyn Therapeutics (OTCMKTS:SIGY) reported earnings of $0.49 per share for Q3. The report was announced on Tuesday, December 2, 2025. When is Sigyn Therapeutics' next earnings date? Sigyn Therapeutics' next earnings date is estimated for Wednesday, November 18, 2026. MarketBeat tracks confirmed and estimated earnings dates for Sigyn Therapeutics on the company's earnings history page. Sigyn Therapeutics Earnings HeadlinesSIGY Sigyn Therapeutics Inc.May 20, 2026 | seekingalpha.comSigyn Therapeutics Launches Initiative to Evaluate Emerging Medical Technologies in Former NFL Players at Risk of CTEApril 2, 2026 | finance.yahoo.comA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the eye-popping yields are fueling a boom among everyday investors. Three years ago, barely a dozen of these funds existed - today there are more than 100, holding over $140 billion. These funds trade on the NYSE and NASDAQ and are built to generate monthly income. Some investors are targeting $5,000 a month with roughly one-tenth of the nest egg Wall Street says you need.October 16 at 1:00 AM | Investors Alley (Ad)Sigyn Therapeutics Delays Annual SEC FilingMarch 31, 2026 | tipranks.comScientific American Highlights Scientific Discovery That Supports the Potential Use of CardioDialysis(TM) to Treat Neuroinflammatory DiseasesMarch 24, 2026 | finance.yahoo.comSigyn Therapeutics Issues Shareholder Update Regarding Potential Merger and Asset Sale InitiativesMarch 13, 2026 | finance.yahoo.comSee More Sigyn Therapeutics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Sigyn Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sigyn Therapeutics and other key companies, straight to your email. Email Address About Sigyn TherapeuticsSigyn Therapeutics (OTCMKTS:SIGY) is a biotechnology company focused on developing therapeutic technologies intended to address systemic inflammation and infectious diseases. Its primary product candidate, Sigyn Therapy, is designed to remove pro-inflammatory cytokines and pathogen-associated materials from circulating blood, with potential applications in conditions such as cancer and severe infections. Sigyn Therapy is an investigational blood-purification technology and has not been established as a commercially approved treatment. The company’s development activities center on evaluating the platform’s ability to modulate immune-system responses and support patients whose diseases or treatments may produce harmful inflammatory reactions. Sigyn Therapeutics is headquartered in the United States and serves the biopharmaceutical and medical-device markets through research and development of its proprietary technology. Publicly available information about the company’s broader commercial operations, geographic reach and current leadership is limited.View Sigyn Therapeutics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Bank of America Stock Sell-Off Looks Like a Buying OpportunityMorgan Stanley Beats on Earnings, But Shares Fall on Trading MixFundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?Palantir's Potential Next Catalyst After Retail Profit-TakingApple Cut iPhone 18 Orders; What Does It Mean For Suppliers?Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But UpFastenal Flashes Bullish Signal as Uptrend Holds Despite Margin Pressure Upcoming Earnings HDFC Bank (10/17/2026)ICICI Bank (10/17/2026)America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026)GE Aerospace (10/20/2026)3M (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
